Dyadic to Attend BIO CEO & Investor Conference and European Industry Events
01 févr. 2024 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Industry Forecast to 2032: U.S. Projected to Maintain Dominance, Driven by Innovative Therapies Entering the Market
30 janv. 2024 07h43 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - Market Insights, Epidemiology, and Market Forecast - 2032" report has been added to ...
Global mRNA Therapeutics Market Set to Reach $21 Billion by 2028 Despite Decline, Fueled by Next-Gen Drugs
25 janv. 2024 09h54 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "mRNA: Therapeutics and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for mRNA therapeutics reached $60...
Next Generation Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2031
25 janv. 2024 09h50 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Next Generation Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology,...
Antibody Therapeutics Industry to Reach $631.3 Billion by 2030: Global Market Analysis, Unveiling the Strategies of Leading Players Roche, AbbVie, J&J, and Merck Among Others
24 janv. 2024 13h49 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Antibody Therapeutics Market Size, Share & Trends Analysis, 2023-2030" report has been added to ResearchAndMarkets.com's offering. The...
Primary Immunodeficiency Therapeutics Market to Surpass $11 Billion by 2030 with Significant Advancement in Genetic Research and Diagnostic Technologies
24 janv. 2024 12h27 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Primary Immunodeficiency Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ...
Global Research Antibodies and Reagents Analysis Report 2023-2030: Emphasis on Proteomics and Genomics Research to Propel Demand
24 janv. 2024 07h02 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Research Antibodies and Reagents Market 2023 - 2030 by Technology, Application, End-user, Product - Partner & Customer Ecosystem Competitive...
Global Research Antibodies Analysis Report 2024: Emerging Opportunities with Expansion into Emerging Countries and Development of Novel Research Antibodies - Forecasts to 2028
17 janv. 2024 04h23 HE
|
Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Global Markets for Research Antibodies" report has been added to ResearchAndMarkets.com's offering. The global market for research antibodies was...
Global Antibody Hit Generation and Screening Market Analysis and Forecast 2023-2032 - Creative Biolabs, F. Hoffmann-La Roche, WuXi AppTec & ICOS Therapeutics Dominate the Market
15 janv. 2024 04h48 HE
|
Research and Markets
Dublin, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The "Global Antibody Hit Generation and Screening Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The...
Global $16.2B Research Antibodies & Reagents Market by Product, Technology, Application, End User & Region - Forecast to 2028
10 janv. 2024 09h38 HE
|
Research and Markets
Dublin, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The "Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow...